Group leader
The awards ceremony was held yesterday at the Caixabanc Auditorium in Girona. IBEC was awarded in the technology centre category in recognition of its twenty years of excellence and interdisciplinary research at the intersection of engineering and life sciences.
A study led by the University of Barcelona in collaboraiton with the Institute for Bioengineering of Catalonia reveals that the functional assay dynamic BH3 profiling (DBP) can predict whether specific treatments will be effective in non-small cell lung cancer patients. The technique helps determine which therapy will be most effective by testing it directly on living cells, improving personalised therapies.
MWC 2025, the leading international event in technology and connectivity, took place in Barcelona this week. The Institute for Bioengineering of Catalonia was present, showcasing some of its spin-offs and participating in conferences and panels on digital health and technology transfer.
Today, the BIST Forum, an event that brings together the BIST scientific community, focused this year on the joint initiative of the seven CERCA centres to promote precision medicine in healthy ageing. During the event, the new BIST Ignite projects to promote multidisciplinary research were announced, with IBEC involved in four of the five selected projects. In addition, one of the projects in which IBEC is involved won a BIST Ignite Award.
The President of the Catalan Government, Salvador Illa, and the Catalan Minister for Research and Universities, Núria Montserrat, inaugurated this unique infrastructure at the Barcelona Science Park today. The microscope, funded by IBEC and FEDER*, opens the door to the reconstruction of biomolecules and viruses in three dimensions, among other applications.
Científicos del Instituto de Bioingeniería de Cataluña (IBEC) y del CIBER-BBN han desarrollado un método que mejora la precisión de los sensores olfativos basados en receptores biológicos. Este avance permite … Read more
A study led by the Institute for Bioengineering of Catalonia (IBEC) and the CIBER’s Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) describes a method that mimics the physiological response to smell. The system makes it possible to discriminate between odours with very similar characteristics based on the binding interaction with the receptor, which causes a change in the capacitive response of the receptor. The application of this methodology opens the door to the development of highly selective olfactory biosensors.
The Institute for Bioengineering of Catalonia and the Sant Joan de Déu Barcelona Children’s Hospital have held a joint conference to strengthen collaboration in bioengineering and translational medicine. The event, held this morning at the IBEC, highlighted innovative projects, presented a joint PhD programme and encouraged the exchange of ideas between researchers from both institutions.
